-+ 0.00%
-+ 0.00%
-+ 0.00%

RAPT Therapeutics Receives FDA Clearance to Begin Phase 2b Clinical Trial of RPT904 for Food Allergy Treatment

Reuters·09/29/2025 09:00:47

Please log in to view news